Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct Prognosis.
Picozza M, Cristofoletti C, Bresin A, Fioretti M, Sambucci M, Scala E, Monopoli A, Cantonetti M, Pilla MA, Accetturi MP, Borsellino G, D'Atri S, Caprini E, Russo G, Narducci MG.
Picozza M, et al. Among authors: bresin a.
J Invest Dermatol. 2022 Nov;142(11):3009-3019.e9. doi: 10.1016/j.jid.2022.04.017. Epub 2022 May 6.
J Invest Dermatol. 2022.
PMID: 35533722
Free article.